Decode Communications

Decode Communications is an independent public relations consultancy founded in 2017 and based in San Diego, United States. The agency focuses on strategic science communications, primarily serving the pharmaceutical, biotech, and life science sectors. With a strong emphasis on translating complex scientific content for diverse audiences, Decode Communications works with organizations navigating pivotal milestones, from clinical trial announcements to regulatory submissions. The San Diego location places the agency in a major hub for biotechnology and medical research, allowing it to stay close to the science it communicates.

Specialized Services for Science-Driven Industries

Decode Communications tailors its offerings to the unique needs of biotech, pharma, and life science companies. The agency’s service set is built around the challenge of making technical information accessible without losing accuracy. Core services include core message development, which helps clients distill complex data into clear, compelling narratives for different stakeholders. Speaker training is another key offering, preparing executives to present at conferences, investor meetings, or media briefings. The agency also provides science writing and medical communications, crafting content for key opinion leaders, care providers, patients, and investors.

In addition to traditional public relations, Decode Communications offers competitor intelligence and regulatory support. These services help clients understand the market landscape and navigate the stringent requirements of the pharmaceutical industry. Grant writing and investor relations are also part of the agency’s repertoire, reflecting the need for funding and strategic partnerships in the biotech space. The agency’s approach to public relations is data-driven, using competitor intelligence to inform positioning and media outreach.

• Core message development
• Speaker training and media coaching
• Science writing and editing
• Medical communications for professionals and patients
• Investor relations and grant writing
• Competitor intelligence and market analysis
• Regulatory support and compliance communications
• Social media strategy for scientific audiences

A Methodical Approach to Science Communications

The methodology at Decode Communications centers on translating science without oversimplifying. The agency starts each engagement by understanding the client’s scientific story, whether it involves a new drug candidate, a clinical trial result, or a regulatory milestone. From there, the team develops core messages tailored to specific audiences—investors, healthcare providers, patients, or the media. This process often involves competitor intelligence to identify gaps and opportunities in the market. The agency’s work in speaker training ensures that clients can deliver these messages confidently and consistently, while social media strategy extends the reach of scientific content to digital platforms.

Decode Communications also emphasizes writing and editing as foundational skills. The agency’s team produces everything from press releases and white papers to grant applications and regulatory documents. This focus on clear, accurate writing helps clients maintain credibility in highly regulated environments. For investor relations, the agency creates materials that highlight scientific progress and commercial potential, supporting fundraising and partnership efforts. The San Diego-based team works remotely with clients across the United States, offering flexible engagement models that range from project-based work to retainer relationships.

Location and Client Fit

Based in San Diego, California, Decode Communications operates at the intersection of science and public relations. The city’s robust biotech ecosystem, including institutions like the University of California San Diego and numerous research parks, provides a natural client base. The agency’s independence allows it to remain agile, taking on work from early-stage startups to established pharmaceutical companies. Decode Communications is a good fit for organizations that need strategic communications support during critical phases such as clinical trial readouts, FDA interactions, or product launches. The agency also suits companies that value a consultative, science-first approach over standard PR tactics. For clients seeking a partner who understands both the science and the business of biotech, Decode Communications offers a focused, experienced alternative to larger agencies.